Background Patients with schizophrenia display peripheral inflammation but the impact of
illness phase is not clear. Our meta-analysis investigated the difference in CRP levels …

Background The systemic immune-inflammation index (SII), system inflammation response
index (SIRI), neutrophil/high-density lipoprotein (HDL) ratio (NHR), lymphocyte/HDL ratio …

Background Cardiovascular disease is a major cause of excess mortality in people with
schizophrenia. Several factors are responsible, including lifestyle and metabolic effects of …

Although significant advances have been made in understanding the patho-physiology of
psychiatric disorders (PDs), therapeutic advances have not been very convincing. While …

Background Individuals with bipolar disorder (BD) face a high risk of heart failure and left
ventricular (LV) dysfunction. Despite strong evidence that high LV relative wall thickness …

Existing data indicate that lithium treatment may reduce the risk of cardiovascular diseases
in patients with bipolar disorder (BD).[[1],[3]] Our recent pilot study demonstrated that longer …

Purpose Long-term hospitalized patients with schizophrenia (SCZ) are vulnerable to
physical illness, leading to impaired life expectancy and treatment outcomes. There are few …

Abstract Ethnopharmacological relevance Shen-Qi-Jiang-Tang granule (SQJTG), a classic
traditional Chinese medicine (TCM) prescription, has been widely used in clinical for …

Schizophrenia is increasingly recognized as a systemic disease, characterized by
dysregulation in multiple physiological systems (eg, neural, cardiovascular, endocrine) …

Patients with schizophrenia have a high risk of cardiovascular death. Increased cardiac left
ventricular (LV) mass has been reported to be associated with heart failure and cardiac …